Deal History
About us
Selskabet
Team
Vores kontorer
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Vækstkapital
IPO Strategi og forberedelse
Industrifokus
Business Services
Consumer / Retail / E-commerce
Industrials
Life Science og Healthcare
Software
Career
Events
Insights
News
Company news
Deal news
Carlsquare in the Media
Newsletter
Kontakt
Newsletter
DA
INT
DE
FR
SV
US
Main menu button
Team
Deals
Kontakt
Team
Deals
Kontakt
News
Alle
Company news
Deal News
Equity Research
Events
I Medier
Insights
Macro and markets
Alle
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Alle
10 mar 2022
Carlsquare to cover Hanza's expansion in the German market
Equity Research
Hanza
09 mar 2022
Research Update Nischer Properties, Q4 2021: Less increase in value but financially strong
Equity Research
Nischer Properties
08 mar 2022
Mrkt BUZZ Pharmiva: A Research and Professional Perspective on Vernivia
Equity Research
08 mar 2022
Research Update Midsummer, Q4 2021: Strong quarter with good growth prospects
Equity Research
Midsummer
08 mar 2022
Initial coverage report Hanza: Clustered Advantages
Equity Research
Hanza
07 mar 2022
Mrkt BUZZ GHP Specialty Care: Cash offer at SEK 35 per share
Equity Research
GHP Specialty Care
03 mar 2022
Mrkt BUZZ Medclair Invest: Explosive growth to be expected in 2022
Equity Research
28 feb 2022
Research update Risk Intelligence, Q4 2021: Initiatives seem to be bearing fruit
Equity Research
Risk Intelligence
28 feb 2022
Research Update Raytelligence, Q4 2021: US gains importance after strategy shift
Equity Research
28 feb 2022
Research Update H&D Wireless, Q4 2021: Slightly lower revenues, but also breakthroughs
Equity Research
28 feb 2022
Research Update Spotlight Group, Q4 2021: Increasing short-term risk
Equity Research
Spotlight Group
28 feb 2022
First Impression, Nischer Properties Q4 2021: Impairment of property value dragged down results
Equity Research
Nischer Properties
25 feb 2022
First impression, Midsummer q4 2021: Strong momentum in both business areas
Equity Research
Midsummer
25 feb 2022
First impression, Raytelligence Q4 2021: Offensive sales target for 2022 maintained
Equity Research
25 feb 2022
First impression, H&D Wireless Q4/2021: Weaker results than expected - but revenues are expected to increase in 2022
Equity Research
25 feb 2022
Research Update SBB i Norden, Q4 2021: Continued capital gains in the properties
Equity Research
SBB i Norden
24 feb 2022
First Impression Pharmiva, Q4, 2021: Progress in Sweden
Equity Research
23 feb 2022
First impressions Risk Intelligence, Q4 2021: In line with expectations and confirmed outlook for the case
Equity Research
Risk Intelligence
23 feb 2022
First impression, SBB i Norden Q4/2021: SEK 2.2 billion in profit from associated companies and higher NRV
Equity Research
SBB i Norden
18 feb 2022
Research Update Ecoclime, Q4 2021: Increased revenues and improved gross margins
Equity Research
1
…
34
35
36
37
38
…
64